VanEck’s Dividend ETF Hits New Records as Exxon’s 45% Profit Plunge Tests Index Rules

VanEck dividend ETF hits record €52.93 with 10% YTD gain, but mixed earnings from top holdings Verizon and ExxonMobil set stage for critical June rebalancing.

The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF has been on a tear. The fund closed Friday at a fresh all-time high of €52.93, pushing its year-to-date gain to nearly 10%. But beneath that headline performance, a more complicated picture is emerging as the ETF’s heavyweights deliver sharply divergent earnings results ahead of a critical June rebalancing.

Investor appetite for income-focused strategies has been voracious. Dividend funds worldwide pulled in roughly $24 billion during the first quarter of 2026, as technology giants redirect capital toward expensive AI projects rather than share buybacks. That rotation has been a tailwind for the VanEck fund, which now manages €7.5 billion in assets — up from €7.4 billion just weeks ago. Morningstar awards the Netherlands-domiciled ETF a Silver Medalist rating, signaling above-average quality in the Global Equity Income category.

Mixed Signals from the Heavy Hitters

Verizon, the fund’s largest holding, delivered a clear positive surprise. The telecoms group posted adjusted earnings of $1.28 per share, comfortably beating analyst estimates, and management raised its full-year guidance. That performance strengthens the case for the stock to retain its top spot in the portfolio.

ExxonMobil tells a different story. While revenue edged up to just over $85 billion, net income cratered by roughly 45% to $4 billion. Management blamed persistent geopolitical tensions in the Middle East for the slump. That kind of profit collapse puts the oil major on shaky ground as the index’s strict rules come into play.

The June Reckoning

The ETF tracks the Morningstar Developed Markets Large Cap Dividend Leaders Screened Select Index, which uses dividend yield as its primary selection criterion but layers on demanding stability requirements. To qualify, a stock must have maintained or increased its dividend over five consecutive years, and its payout ratio cannot exceed 75% of earnings. A single weak quarter can trigger removal.

The semi-annual rebalancing in June will enforce these rules without exception. Individual holdings are capped at 5% of the portfolio, while sector weights are limited to 40%. ESG screens also filter out companies violating the UN Global Compact or involved in controversial business lines.

Financials dominate the allocation at nearly 32%, followed by energy and healthcare stocks. Roche has already cleared one hurdle, reaffirming its annual targets after posting a currency-adjusted sales increase of 6%.

What Income Investors Are Watching

The next concrete date on the calendar is June 4, when the ETF goes ex-dividend. Payment follows a week later, with investors anticipating a distribution of €0.90 per share. That compares with the most recent payout of €0.21 per share, while the fund’s current distribution yield stands at 1.60%.

Pfizer’s earnings, due in May, will close out the reporting season for the top holdings. Only then will it become clear whether the current composition of the top ten positions can withstand the index’s rigorous standards for the June reweighting. For now, the fund’s net asset value per share sits at €52.72, and the relative strength index at 85.8 underscores just how powerful the recent momentum has been.